As an upstream company in cell therapy and molecular diagnosis, stringent requirements for “safety” and “capacity” have been put forward for YOCON products due to their nature. To maximally achieve the goal of “absolutely sterile” production quality, the company has built several large-scale, standardized, and high-end automatic unattended production lines, which are equipped with pharmaceutical-grade injection water systems, CIP, sterilization and dispensing systems, automated high-speed filling system, and automatic blister packaging system, to fully guarantee the daily capacity of 3,000 L for serum-free cell culture products and 400,000 virus sampling products, with quality and quantity assured. YOCON’s recognition of high-quality production determines its high level of production quality. The purpose of the production department is not to accept, manufacture, or deliver nonconforming products.